 |
|
|
|
|
|
|
|
|
|
|
|
1 to 6 of 6 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Zlokovic B. on PAPER: Iliff JJ. et al., 2012, This study importantly adds to our knowledge that passive clearance pathways from the brain... 17 Aug 2012.
|
|
|
 |
|
|
Zlokovic B. on PAPER: Deane R. et al., 2012, We are delighted that this paper generated so much interest. We believe that our findings show... 27 Apr 2012.
|
|
|
|
|
|
Sagare A, Zlokovic B. on PAPER: Hong S. et al., 2011, This paper by Selkoe’s group is an important contribution to our understanding of amyloid-β... 18 Nov 2011.
|
|
|
|
|
|
Zlokovic B. on PAPER: Castellano JM. et al., 2011, This important paper by the Holtzman group establishes the relationship between ApoE4 genotype... 15 Jul 2011.
|
|
|
|
|
|
Zlokovic B. on PAPER: Park L. et al., 2011, This is an important study focusing on cerebrovascular dysfunction as a key target of Aβ... 16 Mar 2011.
|
|
|
|
|
|
Zlokovic B. on NEWS: Aβ, Shifty Drifter? Tissue Grafting Sheds Light on Plaque Formation, Comment by Berislav Zlokovic—Posted 5 March 2003.
The paper by Meyer-Leuchmann et... 5 Mar 2003.
|
|
|
|
|
|
|
1 to 6 of 6 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
